Abstract
Prostaglandin endoperoxide H synthases-1 and -2 (PGHS-1 and -2) catalyze the conversion of arachidonic acid, two molecules of O2 and two electrons to PGH2. This is the committed step in the formation of prostaglandins and thromboxane A2 [1]. Crystallographic studies of enzyme inhibitor complexes have suggested that the cyclooxygenase active sites of PGHSs are hydrophobic channels that protrude into the body of the major globular domain of the enzymes [2]. We have now determined the structure of arachidonic acid (AA) bound within the cyclooxygenase active site of ovine (o)PGHS-1 [3]. AA is bound in an extended L-shaped conformation and makes a total of 49 hydrophobic contacts (i.e. 2.5–4.0 Å) and two hydrophilic contacts with the protein involving a total of 19 different residues (Figures 1,2). Although AA can assume some 107 low energy conformations [4], only three of these are catalytically competent [5]. One conformation leads to PGG2, one leads to 11R-HPETE, and a third leads to 15R- plus 15S-HPETE. Previous mutational studies have established the importance of Arg120 in AA binding to PGHS-1 and -2 [6–8], the role of Tyr385 in abstraction of the 13-proS-hydrogen from AA [9,10] and the importance of Ser530 and I1e523 as determinants of inhibitor specificity [11–13]. We have performed mutational analyses of a number of the residues that line the cyclooxygenase channel to determine their functional importance in AA binding and oxygenation. Substitutions of several cyclooxygenase site residues lead to large increases in 11-HPETE or 15-HPETE formation but with small changes in the Km for AA. Our results suggest that individually and collectively the hydrophobic residues function primarily to position AA in a specific conformation that optimizes its conversion to PGG2.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular and molecular biology. Annu Rev Biochem 2000; 69: 149–82.
Picot D, Loll PJ, Garavito M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-l. Nature 1994; 367: 243–49.
Malkowski MG, Ginell S, Smith WL, Garavito RM. The x-ray crystal structure of prostaglandin endoperoxide H synthase-1 complexed with arachidonic acid. Science 2000; in press.
Gund P, Shen TY. A model for the prostaglandin synthetase cyclooxygenation site and its inhibition by antiinflammatory arylacetic acids. J Med Chem 1977; 9: 1146–52.
Thuresson ED, Lakkides KM, Smith WL. Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. J Biol Chem 2000; 275: 8501–7.
Mancini JA, Riendeau D, Falgueyret JP, Vickers PJ, O’Neill GP. Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety. J Biol Chem 1995; 270 (49): 29372–77.
Bhattacharyya DK, Lecomte M, Rieke CJ, Garavito M, Smith WL. Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1. J BiolChem 1996; 271 (4): 2179–84.
Rieke CJ, Mulichak AM, Garavito RM, Smith WL. The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors. J Biol Chem 1999; 274 (24): 17109–14.
Shimokawa T, Kulmacz RJ, DeWitt DL, Smith WL. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis. J Biol Chem 1990; 265 (33): 20073–76.
Tsai A, Hsi LC, Kulmacz RJ, Palmer G, Smith WL. Characterization of the tyrosyl radicals in ovine prostaglandin H synthase-1 by isotope replacement and site-directed mutagenesis. J Biol Chem 1994; 269 (7): 5085–91.
DeWitt DL, El-Harith EA, Kraemer SA, et al. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J Biol Chem 1990; 265 (9): 5192–98.
Shimokawa T, Smith WL. Prostaglandin endoperoxide synthase: the aspirin acetylation region. J Biol Chem 1992; 267: 12387–92.
Guo Q, Wang LH, Ruan KH, Kulmacz RJ. Role of Va1509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents. J Biol Chem 1996; 271 (32): 19134–39.
Loll PJ, Picot D, Garavito RM. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol 1995; 2: 637–643.
Hsi LC, Hoganson CW, Babcock GT, Garavito RM, Smith WL. An examination of the source of the tyrosyl radical in ovine prostaglandin endoperoxide synthase-1. Biochem Biophys Res Commun 1995; 207 (2): 652–60.
Rowlinson SW, Crews BC, Lanzo CA, Marnett LJ. The binding of arachidonic acid in the cyclo-oxygenase site of mouse prostaglandin endoperoxide sythase-2 (COX-2). J Biol Chem 1999; 274 (33): 23305–10.
Schneider C, Brash AR. Stereospecificity of hydrogen abstraction in the conversion of arachidonic acid to 15R-HETE by aspirin-treated cyclooxygenase-2: implications for the alignment of substrate in the active site. J Biol Chem 2000; 275: 4743–46.
Hsi LC, Tsai AL, Kulmacz RJ, et al. Trp387 and the putative leucine zippers of PGH synthases-1 and -2. J. Lipid Mediat 1993; 6 (1–3): 131–38.
Xiao G, Tsai AL, Palmer G, Boyar WC, Marshall PJ, Kulmacz RI. Analysis of hydroperoxide-inducedtyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2. Biochemistry 1997; 36 (7): 1836–45.
Lecomte M, Laneuville O, Ji C, DeWitt DL, Smith WL. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 1994; 269 (18): 13207–15.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Thuresson, E.D. et al. (2001). Substrate Interactions in the Cyclooxygenase-1 Active Site. In: Samuelsson, B., Paoletti, R., Folco, G.C., Granström, E., Nicosia, S. (eds) Advances in Prostaglandin and Leukotriene Research. Medical Science Symposia Series, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9721-0_10
Download citation
DOI: https://doi.org/10.1007/978-94-015-9721-0_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5881-2
Online ISBN: 978-94-015-9721-0
eBook Packages: Springer Book Archive